NCT04217161

Dexcom G6 Continuous Glucose Monitoring in Hemodialysis

Comparison of Dexcom G6 Continuous Glucose Monitoring System and Blood Glucose Levels in Adult Hemodialysis Patients With Diabetes

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: University of California, Irvine · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a pilot study enrolling adult hemodialysis patients with diabetes recruited from the University of California Irvine Medical Center (UCIMC) who will undergo simultaneous measurement of glucose levels using 1) continuous glucose monitor (CGM) measured by a Dexcom G6 device vs. 2) "gold-standard" blood glucose levels using capillary fingerstick or venous blood glucose measurements obtained on a point of care (POC) blood glucose meter. The study will assess Dexcom G6 accuracy by comparing glucose levels on the CGM device vs. blood glucose measurements in the study population.

Conditions

• Diabetes
• Hemodialysis
• Glucose Measurement

Interventions

Type	Name	Description
DEVICE	Dexcom G6 Continuous Glucose Monitor	Eligible patients will undergo DDexcom G6 Continuous Glucose Monitor device placement

Timeline

• Start date: 2020-03-01
• Primary completion: 2023-12-21
• Completion: 2023-12-21
• First posted: 2020-01-03
• Last updated: 2023-06-12

Locations

1 site across 1 country: United States